找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drugs between Research and Regulations; Proceedings of the 5 C. Steichele (Medizinischer Direktor),U. Abshagen Conference proceedings 1985

[復(fù)制鏈接]
樓主: 無感覺
11#
發(fā)表于 2025-3-23 12:24:24 | 只看該作者
https://doi.org/10.1007/978-1-4842-4950-5sons and, at least in Italy, the law prevent the GP from taking a direct part in the first phases of clinical research; on the other hand, even after the introduction of a medicine onto the market, the general practitioner’s involvement is considered to be that of prescription rather than evaluation.
12#
發(fā)表于 2025-3-23 16:21:52 | 只看該作者
Installing Third-Party Libraries,linical trials, with special reference to drug evaluation after marketing (Phase IV). I shall deal with it from the vantage of a decade and a half of consultation work in this area, especially with the Drug Epidemiology Unit of Boston University School of Medicine.
13#
發(fā)表于 2025-3-23 19:48:03 | 只看該作者
Clinical guidelines — a help or a hindrance?cceed, now and again, in thwarting their deliberations and obscuring their aims. The issue of Guidelines for the Clinical Investigation of Drugs is a case in point. They are hailed by some and condemned by others and nine tenths of the problem is that the one party really has little idea what the other party is talking about.
14#
發(fā)表于 2025-3-23 23:51:22 | 只看該作者
15#
發(fā)表于 2025-3-24 03:04:13 | 只看該作者
Alternatives to clinical trials in post-marketing research on drug effectslinical trials, with special reference to drug evaluation after marketing (Phase IV). I shall deal with it from the vantage of a decade and a half of consultation work in this area, especially with the Drug Epidemiology Unit of Boston University School of Medicine.
16#
發(fā)表于 2025-3-24 07:28:05 | 只看該作者
Managing Device Drivers and PC ResourcesRisk: benefit decision making lies at the heart of modern therapeutics, and it is possible to distinguish between four categories of problem.
17#
發(fā)表于 2025-3-24 10:44:29 | 只看該作者
18#
發(fā)表于 2025-3-24 14:49:36 | 只看該作者
The organisation of long-term intervention and prevention studiesRisk: benefit decision making lies at the heart of modern therapeutics, and it is possible to distinguish between four categories of problem.
19#
發(fā)表于 2025-3-24 20:33:56 | 只看該作者
20#
發(fā)表于 2025-3-25 00:30:33 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-28 13:20
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
柳河县| 上虞市| 铜川市| 乌兰浩特市| 神木县| 瑞丽市| 辉县市| 宣化县| 玉树县| 都江堰市| 岗巴县| 海伦市| 乌鲁木齐市| 长泰县| 卢龙县| 涪陵区| 翼城县| 十堰市| 洛浦县| 利津县| 永宁县| 九江县| 庆城县| 苗栗县| 抚顺县| 大埔区| 集贤县| 泊头市| 平南县| 三台县| 灵石县| 长汀县| 安顺市| 龙泉市| 白河县| 若羌县| 宕昌县| 定结县| 塔城市| 台北市| 固安县|